Related references
Note: Only part of the references are listed.A meta-analysis of the efficacy of gabapentin for treating alcohol use disorder
Henry R. Kranzler et al.
ADDICTION (2019)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Posttraumatic stress disorder and tobacco use: A systematic review and meta-analysis
Irene Pericot-Valverde et al.
ADDICTIVE BEHAVIORS (2018)
A Randomized, Placebo-controlled, Clinical Trial of Prazosin for the Treatment of Alcohol Use Disorder
Claire E. Wilcox et al.
JOURNAL OF ADDICTION MEDICINE (2018)
Pilot investigation of the effect of carvedilol on stress-precipitated smoking-lapse behavior
Terril L. Verplaetse et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
Noradrenergic targets for the treatment of alcohol use disorder
Carolina L. Haass-Koffler et al.
PSYCHOPHARMACOLOGY (2018)
Double-Blind Randomized Clinical Trial of Prazosin for Alcohol Use Disorder
Tracy L. Simpson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Doxazosin for the treatment of co-occurring PTSD and alcohol use disorder: Design and methodology of a randomized controlled trial in military veterans
Sudie E. Back et al.
CONTEMPORARY CLINICAL TRIALS (2018)
The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Louisa Degenhardt et al.
LANCET PSYCHIATRY (2018)
Effect of doxazosin on stress reactivity and the ability to resist smoking
Terril L. Verplaetse et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
Common physiological basis for post-traumatic stress disorder and dependence to drugs of abuse: Implications for new therapeutic approaches
Pascale Gisquet-Verrier et al.
THERAPIE (2017)
Effect of Selective Inhibition of Reactivated Nicotine-Associated Memories With Propranolol on Nicotine Craving
Yan-Xue Xue et al.
JAMA PSYCHIATRY (2017)
Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin
Carolina L. Haass-Koffler et al.
DRUG AND ALCOHOL DEPENDENCE (2017)
Role of the 1 blocker doxazosin in alcoholism: a proof-of-concept randomized controlled trial
George A. Kenna et al.
ADDICTION BIOLOGY (2016)
Prazosin for Veterans with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence: A Clinical Trial
Ismene L. Petrakis et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2016)
Prazosin Reduces Alcohol Intake in an Animal Model of Alcohol Relapse
Janice C. Froehlich et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2015)
A Pilot Trial of Prazosin, an Alpha-1 Adrenergic Antagonist, for Comorbid Alcohol Dependence and Posttraumatic Stress Disorder
Tracy L. Simpson et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2015)
A translational investigation targeting stress-reactivity and prefrontal cognitive control with guanfacine for smoking cessation
Sherry A. Mckee et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Combining the 1-Adrenergic Receptor Antagonist, Prazosin, with the -Adrenergic Receptor Antagonist, Propranolol, Reduces Alcohol Drinking More Effectively Than Either Drug Alone
Dennis D. Rasmussen et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2014)
Trauma Reactivation Plus Propranolol Is Associated With Durably Low Physiological Responding During Subsequent Script-Driven Traumatic Imagery
Alain Brunet et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2014)
Connecting the pathology of posttraumatic stress and substance use disorders: Monoamines and neuropeptides
Nicole M. Enman et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
The 1-Adrenergic Receptor Antagonist, Doxazosin, Reduces Alcohol Drinking in Alcohol-Preferring (P) Rats
Meghan L. O'Neil et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2013)
Prazosin Reduces Alcohol Drinking Throughout Prolonged Treatment and Blocks the Initiation of Drinking in Rats Selectively Bred for High Alcohol Intake
Janice C. Froehlich et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2013)
The alpha-1 adrenergic antagonist doxazosin for treatment of cocaine dependence: A pilot study
D. Shorter et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
Enhanced noradrenergic activity potentiates fear memory consolidation and reconsolidation by differentially recruiting α1- and β-adrenergic receptors
Lucas Gazarini et al.
LEARNING & MEMORY (2013)
Prazosin Effects on Stress- and Cue-Induced Craving and Stress Response in Alcohol-Dependent Individuals: Preliminary Findings
Helen C. Fox et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2012)
Effects of Prazosin, an α1-Adrenergic Receptor Antagonist, on the Seeking and Intake of Alcohol and Sucrose in Alcohol-Preferring (P) Rats
Terril L. Verplaetse et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2012)
Effect of Acute Posttrauma Propranolol on PTSD Outcome and Physiological Responses During Script-Driven Imagery
Elizabeth A. Hoge et al.
CNS NEUROSCIENCE & THERAPEUTICS (2012)
Review of biological mechanisms and pharmacological treatments of comorbid PTSD and substance use disorder
Sonya B. Norman et al.
NEUROPHARMACOLOGY (2012)
Effects of Adrenal Sensitivity, Stress- and Cue-Induced Craving, and Anxiety on Subsequent Alcohol Relapse and Treatment Outcomes
Rajita Sinha et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Trauma Reactivation Under the Influence of Propranolol Decreases Posttraumatic Stress Symptoms and Disorder 3 Open-Label Trials
Alain Brunet et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2011)
Stimulation of α2-adrenergic receptors in the central nucleus of the amygdala attenuates stress-induced reinstatement of nicotine seeking in rats
Hidetaka Yamada et al.
NEUROPHARMACOLOGY (2011)
Effect of prazosin and guanfacine on stress-induced reinstatement of alcohol and food seeking in rats
A. D. Le et al.
PSYCHOPHARMACOLOGY (2011)
Noradrenergic α1 Receptors as a Novel Target for the Treatment of Nicotine Addiction (vol 35, pg 1751, 2010)
Benoit Forget et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Effects of β-adrenoceptor antagonists on alcohol drinking by alcohol-dependent rats
Nicholas W. Gilpin et al.
PSYCHOPHARMACOLOGY (2010)
Effects of prazosin, clonidine, and propranolol on the elevations in brain reward thresholds and somatic signs associated with nicotine withdrawal in rats
Adrie W. Bruijnzeel et al.
PSYCHOPHARMACOLOGY (2010)
The α1-Adrenergic Receptor Antagonist, Prazosin, Reduces Alcohol Drinking in Alcohol-Preferring (P) Rats
Dennis D. Rasmussen et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2009)
A Pilot Trial of the Alpha-1 Adrenergic Antagonist, Prazosin, for Alcohol Dependence
Tracy L. Simpson et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2009)
Brain stress systems in the amygdala and addiction
George F. Koob
BRAIN RESEARCH (2009)
The alpha(1) adrenergic receptor antagonist prazosin reduces heroin self-administration in rats with extended access to heroin administration
Thomas N. Greenwell et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
α1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol
Brendan M. Walker et al.
ALCOHOL (2008)
Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings
Bankole A. Johnson
BIOCHEMICAL PHARMACOLOGY (2008)
Uncoupling between noradrenergic and serotonergic neurons as a molecular basis of stable changes in behavior induced by repeated drugs of abuse
Jean-Pol Tassin
BIOCHEMICAL PHARMACOLOGY (2008)
Post-retrieval β-adrenergic receptor blockade:: Effects on extinction and reconsolidation of cocaine-cue memories
Ashley N. Fricks-Gleason et al.
LEARNING & MEMORY (2008)
A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms
Kyle M. Kampman et al.
DRUG AND ALCOHOL DEPENDENCE (2006)
The efficacy of motivational interviewing as a brief intervention for excessive drinking: A meta-analytic review
EI Vasilaki et al.
ALCOHOL AND ALCOHOLISM (2006)
Smoking as a complex but critical covariate in neurobiological studies of posttraumatic stress disorders: a review
Ann M. Rasmusson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2006)
Doxazosin for treating lower urinary tract symptoms compatible with benign prostatic obstruction: a systematic review of efficacy and adverse effects
R MacDonald et al.
BJU INTERNATIONAL (2004)
Disruption of reconsolidation but not consolidation of auditory fear conditioning by noradrenergic blockade in the amygdala
J Debiec et al.
NEUROSCIENCE (2004)
Prazosin reduces trauma-related nightmares in older men with chronic posttraumatic stress disorder
ER Peskind et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2003)
Twenty-four week maintenance treatment of cigarette smoking with nicotine gum, clonidine and naltrexone
J Ahmadi et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2003)
Terazosin, doxazosin, and prazosin: Current clinical experience
B Akduman et al.
UROLOGY (2001)
Substance use disorders in patients with posttraumatic stress disorder: A review of the literature
LK Jacobsen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity
KM Kampman et al.
DRUG AND ALCOHOL DEPENDENCE (2001)
The α1-adrenergic antagonist prazosin ameliorates combat trauma nightmares in veterans with posttraumatic stress disorder:: A report of 4 cases
MA Raskind et al.
JOURNAL OF CLINICAL PSYCHIATRY (2000)